Titan Pharmaceuticals, Inc.
(NASDAQ : TTNP)

( )
TTNP PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
ABBVAbbVie, Inc. -0.96%92.131.9%$1192.97m
JNJJohnson & Johnson -0.87%144.440.7%$1057.09m
BMYBristol-Myers Squibb Co. -0.57%60.791.0%$967.46m
PFEPfizer Inc. 0.64%37.500.9%$831.88m
MRKMerck & Co., Inc. -0.22%76.380.7%$796.50m
LLYEli Lilly & Co. -0.69%151.231.1%$417.06m
AZNAstraZeneca Plc -0.11%55.221.2%$261.94m
NVSNovartis AG -0.09%84.910.2%$156.50m
GSKGlaxoSmithKline Plc -0.37%40.880.2%$140.53m
NVONovo Nordisk A/S 0.05%64.850.1%$87.00m
SNYSanofi -0.30%47.300.2%$78.78m
RGENRepligen Corp. -0.57%139.517.1%$73.05m
ARCTArcturus Therapeutics Holdings, Inc. 7.71%58.270.0%$60.48m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 11.80%58.370.0%$42.40m
RETAReata Pharmaceuticals, Inc. 1.04%160.003.4%$38.83m

Company Profile

Titan Pharmaceuticals, Inc. engages in development of therapeutics for the treatment of chronic diseases utilizing its long-term, continuous drug delivery platform, ProNeura. Its lead product is Probuphine, a buprenorphine implant for the maintenance treatment of opioid addiction. The company was founded by Louis R. Bucalo in February 7, 1992 and is headquartered in South San Francisco, CA.